Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04806425
NCT04806425
Completed
Phase 4

The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery Revascularization

Ain Shams University1 site in 1 country46 target enrollmentOctober 1, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAnesthesia
InterventionsIntralipidPlacebo

Overview

Phase
Phase 4
Intervention
Intralipid
Conditions
Anesthesia
Sponsor
Ain Shams University
Enrollment
46
Locations
1
Primary Endpoint
ICU stay
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

the aim of the study is to assess the effect of intralipid as regard efficiency in decreasing myocardial ischemia , given during preconditioning in off pump coronary artery revascularization

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
March 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •patients between 40 to 75 undergoing off bump CABG surgery

Exclusion Criteria

  • •emergency surgery
  • •Ejection fraction less than 50%
  • •redo procedures
  • •history of allergy to peanuts

Arms & Interventions

IL group

receive 1.5 ml /kg intralipid 20% through Central venous line after sternotomy over 1 hour

Intervention: Intralipid

NS group

recieve 1.5 ml /kg normal saline 0.9% through central venous line after sternotomy over 1 hour

Intervention: Placebo

Outcomes

Primary Outcomes

ICU stay

Time Frame: long icu stay is considered if more than 7 days

measuring the duration of stay in the ICU

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
Evaluation of Intralipid efficacy for decreasing Amphotericin B-related nephrotoxicity
IRCT2012110411364N1Vice chancellor for research, Tehran University of Medical Sciences30
Unknown
Not Applicable
Lipid Emulsion in Cardiac Valve Replacement SurgeryIschemic Reperfusion Injury
NCT04951791Assiut University68
Completed
Phase 4
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target LevelsCardiovascular DiseaseCerebrovascular AccidentCoronary Heart Disease
NCT00327691Pfizer8,600
Not yet recruiting
Phase 3
EFFECT OF DRUG INTRALIPID FOR HEART PROTECTION IN HEART SURGERY (CORONARY ARTERY BYPASS SURGERY) ; PROSPECTIVE RANDOMIZED CONTROL STUDY IN DEPARTMENT OF ANAESTHESIA , SMS MEDICAL COLLEGE JAIPUR
CTRI/2023/11/059964SMS MEDICAL COLLEGE AND ATTACHED HOSPITAL JAIPUR
Completed
Phase 2
Investigation of the effect of interalipid on aluminum phosphide poisoning
IRCT20220618055207N1Tehran University of Medical Sciences60